Genetix Biotherapeutics is a startup based in the United States.
Based in the United States, Genetix Biotherapeutics is a startup.
Genetix Biotherapeutics (formerly bluebird bio) develops one-time administered gene therapies that target the underlying causes of rare genetic diseases, including sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy. The company focuses on advancing first-in-class genetic therapies from development toward patient access.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.